report fiscal adjust ep
consensu expect higher estim quarter
benefit lower-than-anticip adjust incom tax account
upsid versu consensu expect rel estim
compani tax benefit mostli off-set higher adjust oper
expens forecast
total debt total asset
ste fiscal revenu increas year-over-year million
slightli consensu expect million
million estim quarter report constant
currenc organ growth forecast
weak result healthcar equip low-double-digit organ
offset strong perform across remaind busi
capit sale obvious lumpi surpris see second
straight quarter neg organ growth ste healthcar capit
busi appear stabl market said order backlog
ste healthcar equip busi year-over-year exit
fiscal suggest sign favor outlook enter fiscal
includ bp organ basi bp
estim would guess similar consensu quarter
adjust gross margin strong bp year-over-year
aid bp benefit divestitur oper expens
higher anticip reflect impact divest higher
ste combin order backlog healthcar life scienc product
increas year-over-year million end fiscal led
except strong demand life scienc capit year-over-
year million
maintain constant currenc organ growth guidanc
addit compani rais adjust ep outlook
reflect tax benefit fiscal
oper perform toward upper end prior rang compani
also rais free cash flow guidanc million million
certain capit expenditur push ste
preliminari expect low adjust tax rate due expect
benefit tax reform
rais adjust ep estim
respect primarili result tax reform
benefit encourag compani strong fiscal result outsid
healthcar capit expect headwind segment eas
maintain buy rate increas price target
import pleas read disclosur disclaim page report
report fiscal adjust ep consensu expect higher
estim quarter benefit lower-than-anticip adjust incom tax account
upsid versu consensu expect rel estim compani tax benefit
mostli off-set higher adjust oper expens forecast
ste fiscal revenu increas year-over-year million slightli consensu
expect million million estim quarter report constant
currenc organ growth forecast weak result healthcar
plcfiscal adjust incom statement revenu analysisnorthcoast research thousand except percentag per share gross sg sg oper oper interest expens incom incom tax incom extra margin extra incom com share growth ep growth life appli steril healthcar specialti compani report northcoast research estim factset equip offset strong perform across remaind busi note ste report
constant currenc organ growth includ impact smaller acquisit exclud smaller acquisit
compass medic genii apono medic padlock clip defect closur system estim
compani fiscal organ growth rang versu forecast
growth posit fiscal also exclud compani acquisit genii apono medic
padlock clip defect closur system estim ste healthcar product organ growth closer neg
well estim
steri plcorgan growth analysi benefit signific year-over-year increas shipment hurt difficult year-over-year comparison shipmentssourc compani report northcoast research plchealthcar product organ growth analysi benefit signific year-over-year increas shipment hurt difficult year-over-year comparison shipmentssourc compani report northcoast research worse-than-expect organ growth ste healthcar equip busi roughli year-over-
year account downsid versu expect quarter result compani healthcar
consum approxim organ aid robust growth biolog indic healthcar
servic roughli organ segment remain strong healthcar equip indic growth
infect prevent technolog busi better surgic suit equip segment
quarter furthermor discuss fall-off healthcar capit sale point slowdown growth
categori busi post except result prior year includ
integr hydrogen peroxid steril vpro line well weak equip manag
steam steril time order deliveri also appear hurt quarter healthcar capit
order backlog year-over-year exit fiscal
ste healthcar equip backlog rel strong enter fiscal compani appear cautiou
next quarter outlook segment given tough prior year comparison ste healthcar equip
sale low-double-digit organ fiscal said think combin new product
opportun much easier comparison help return ste healthcar capit growth least
long-term averag positive-low-single-digit rang
fiscal ste life scienc busi post organ growth well estim
expect compani life scienc capit sale year-over-year particularli strong driven
robust order backlog enter quarter addit ste life scienc consum servic revenu
grew mid-single-digit rate organ fiscal moreov compani life scienc growth expect
remain elev next quarter aid compani life scienc backlog
year-over-year million exit fiscal
steri plcorder backlog analysi northcoast researchord backlog order scienc order scienc compani report northcoast research estim aid black diamond video acquisit
ste appli steril ast busi achiev organ growth fiscal
well forecast revenu headwind compani puerto rico ast facil bad
expect neg million impact profit versu guidanc neg million facil
return normal oper decemb versu ste prior expect linger million hit
profit fiscal addit point strong medic devic volum like market share gain
factor aid ast result quarter
ste healthcar specialti servic busi achiev report organ growth fiscal howev
compani acquisit compass medic lump report organ growth exclud
estim acquisit contribut believ organ growth closer still
forecast quarter organ growth clearli benefit divestitur
compani lower-growth linen manag busi netherland unit state unit kingdom
well reclassif sterilm busi ast legaci synergi health outsourc steril process
busi continu post favor result organ growth legaci ste instrument repair busi
ri plclife scienc divis organ growth analysissourc compani report northcoast research plcappli steril technolog divis organ growth analysissourc compani report northcoast research appear stabil mid-single-digit rang exclud compass medic acquisit
posit provid mani specif quarter revenu northwel outsourc steril
process project begin compani expect contribut busi moreov
compani suggest may new outsourc steril process contract discuss fiscal
earn call may
ste fiscal adjust oper margin increas bp year-over-year includ bp organ
basi bp estim would guess similar consensu
quarter adjust gross margin strong bp year-over-year aid bp
benefit divestitur oper expens higher anticip reflect impact
divest higher performance-bas compens expens busi segment standpoint adjust
oper margin expans particularli strong healthcar specialti servic bp year-over-year
aid divestitur improv instrument repair
maintain constant currenc organ growth guidanc addit compani rais
adjust ep outlook reflect tax benefit fiscal
oper perform toward upper end prior rang compani also rais free cash flow
guidanc million million certain capit expenditur push
ste preliminari expect low adjust tax rate due expect benefit tax reform
ri plchealthcar specialti servic divis organ growth analysi compani report northcoast research plcadjust oper margin healthcar life appli steril healthcar specialti compani report northcoast research overal rais adjust ep estim
respect primarili result tax reform benefit encourag compani strong fiscal
result outsid healthcar capit expect headwind segment eas
maintain buy rate increas price target
steri plcannual incom statement analysi adjust northcoast research thousand except percent per share gross gross sg sg oper oper net interest expens incom incom incom tax minor net incom extra net margin extra extra net incom continu net wghd com share ep ep revenu growth adjust ep growth compani report northcoast research estim disclosur
